Xiaoping Xu

机构：Tianjin Agricultural University, Shanghai Medical College of Fudan University, Tianjin University, The University of Texas at San Antonio Health Science Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, Fudan University, Fudan University Shanghai Cancer Center, Institute of Modern Physics, United Imaging Healthcare (China), Dezhou University · ORCID：0000-0001-9656-6233

发表论文 343 篇 · 总被引 4305 次 · h-index 35

代表论文

• Pilot Study of Nectin-4–Targeted PET Imaging Agent 68 Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human (2025 · Journal of Nuclear Medicine · 被引 25)
• Preclinical Evaluation of 68 Ga-Labeled SL1 Aptamer for c-Met Targeted PET Imaging (2025 · Molecular Pharmaceutics · 被引 8)
• Nomogram for Deep Vein Thrombosis Prediction Post‐Endovascular Thrombectomy in Acute Ischemic Stroke: A Retrospective Multicenter Observational Study (2025 · Journal of Clinical Nursing · 被引 5)
• Predicting [177Lu]Lu‐DOTA‐TATE dosimetry by using pre‐therapy [68Ga]Ga‐DOTA‐TATE PET/CT and biomarkers in patient with neuroendocrine tumors (2025 · Medical Physics · 被引 3)
• Linker-DrivenBreakthrough: Design of a Novel Linkerfor Enhanced Theranostic Performance of FAPI Trimer (2025 · Journal of Medicinal Chemistry · 被引 2)
• A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG (2025 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 2)